Literature DB >> 31747602

3D Cellular Architecture Modulates Tyrosine Kinase Activity, Thereby Switching CD95-Mediated Apoptosis to Survival.

Gülce S Gülcüler Balta1, Cornelia Monzel2, Susanne Kleber3, Joel Beaudouin4, Emre Balta5, Thomas Kaindl2, Si Chen3, Liang Gao3, Meinolf Thiemann6, Christian R Wirtz7, Yvonne Samstag5, Motomu Tanaka8, Ana Martin-Villalba9.   

Abstract

The death receptor CD95 is expressed in every cancer cell, thus providing a promising tool to target cancer. Activation of CD95 can, however, lead to apoptosis or proliferation. Yet the molecular determinants of CD95's mode of action remain unclear. Here, we identify an optimal distance between CD95Ligand molecules that enables specific clustering of receptor-ligand pairs, leading to efficient CD95 activation. Surprisingly, efficient CD95 activation leads to apoptosis in cancer cells in vitro and increased tumor growth in vivo. We show that allowing a 3D aggregation of cancer cells in vitro switches the apoptotic response to proliferation. Indeed, we demonstrate that the absence or presence of cell-cell contacts dictates the cell response to CD95. Cell contacts increase global levels of phosphorylated tyrosines, including CD95's tyrosine. A tyrosine-to-alanine CD95 mutant blocks proliferation in cells in contact. Our study sheds light into the regulatory mechanism of CD95 activation that can be further explored for anti-cancer therapies.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD95; CD95 ligand; apoptosis; cancer; cell-cell contact; death receptors; supported membrane; survival; tyrosine kinase

Year:  2019        PMID: 31747602     DOI: 10.1016/j.celrep.2019.10.054

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  7 in total

Review 1.  Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer.

Authors:  Elodie Lafont
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

Review 2.  CD95 Structure, Aggregation and Cell Signaling.

Authors:  Nicolas Levoin; Mickael Jean; Patrick Legembre
Journal:  Front Cell Dev Biol       Date:  2020-05-05

3.  CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells.

Authors:  Abdul S Qadir; Jean Philippe Guégan; Christophe Ginestier; Assia Chaibi; Alban Bessede; Emmanuelle Charafe-Jauffret; Manon Macario; Vincent Lavoué; Thibault de la Motte Rouge; Calvin Law; Jacob Vilker; Hongbin Wang; Emily Stroup; Matthew J Schipma; Bryan Bridgeman; Andrea E Murmann; Zhe Ji; Patrick Legembre; Marcus E Peter
Journal:  iScience       Date:  2021-10-29

4.  Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing.

Authors:  Annelies Van Hemelryk; Lisanne Mout; Sigrun Erkens-Schulze; Pim J French; Wytske M van Weerden; Martin E van Royen
Journal:  Biomolecules       Date:  2021-10-22

5.  CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner.

Authors:  Clara Quijano-Rubio; Manuela Silginer; Michael Weller
Journal:  Cell Death Discov       Date:  2022-07-29

6.  Clusters of apoptotic signaling molecule-enriched rafts, CASMERs: membrane platforms for protein assembly in Fas/CD95 signaling and targets in cancer therapy.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  Biochem Soc Trans       Date:  2022-06-30       Impact factor: 4.919

7.  Functionalized supported membranes for quantifying adhesion of P. falciparum-infected erythrocytes.

Authors:  Benjamin Fröhlich; Anil K Dasanna; Christine Lansche; Julian Czajor; Cecilia P Sanchez; Marek Cyrklaff; Akihisa Yamamoto; Alister Craig; Ulrich S Schwarz; Michael Lanzer; Motomu Tanaka
Journal:  Biophys J       Date:  2021-07-09       Impact factor: 3.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.